可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] 王安才,成蓓. 强化调脂治疗,加强冠心病防治[J]. 皖南医学院学报,2002,21(1):1-3.
[2] 秦晋梅,李建军. 他汀类药物的抗炎作用[J]. 中国动脉硬化杂志,2004,12(3):363-365.
[3] 覃军,李爱民,何作云. 他汀类药物对血管平滑肌细胞的直接作用及其意义[J]. 中国动脉硬化杂志,2000,8(4):373-375.
[4] 谢良地. HMGCOA还原酶抑制剂的非调脂作用及机制(上)[J]. 高血压杂志,2004,12(3):265-269.
[5] Wassmann S, Laufs U, Baumer AT, et al. HMG CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species[J]. Hypertersion, 2001,37(6):1450-1457.
[6] 王安才,成蓓,谢晓竟,等. 阿托伐他汀对自发性高血压大鼠心室重构的影响[J]. 中国临床药理学与治疗学,2004,9(8):880-884.
[7] Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy[J]. Circulation, 2001,104(3):317-324.
[8] 徐琳,李志梁,李高中,等. 辛伐他汀对血管升压素诱导心脏成纤维细胞增殖和胶原合成的影响[J]. 心脏杂志,2006,18(2):190-193.
[9]蒋蕾,邱蕾,汪耀. ASCOT研究简介与评议[J].实用糖尿病杂志,2005,13(1):15-16.
[10]Borghi C, Prandin MG, Costa FV, et al. Use of statins and blood pressure control in hypertensive patients with hypercholesterolemia[J]. J Cardiovasc Pharmacol, 2000,35(4):549-555.
[11]Watanabe T,Itokawa M,Nakagawa N,et al .Increased levels of insulinlike growth factor binding protein3 in hypertensive patients with carotid atherosclerosis [J] . Am J Hypertens,2003,16(9 pt 1):754-760.
[12]杨月榕,吴欣,陈佳,等.氟伐他汀对老年高血压病患者内皮依赖性血管舒张功能影响的研究[J].中国全科医学,2003,6(1):32-34.
[13]Su SF, Hsiao CL, Chu CW, et al. Effects of pravastatin of left ventricular mass in patients with hyperlipidemia and essential hypertension[J]. Am J Cardiol, 2000,86(5):514-518.
[14]Dechend R, Fiebeler A, Park JK, et al. Amelioration of angiotensinⅡinduced cardiac injury by a 3hydroxy3methylglutaryl coenzyme, a reductase inhibitor[J]. Circulation, 2001,104(5):576-581.
[15]Ichiki T, Takeda K, Tokunou T, et al. Downregulation of angiotensinⅡtype 1 receptor by hydrophobic 3hydroxy3methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol, 2001,21(12):1896-1901.
[16]Kamide K,Hori MT,Zhu JH,et al. Insulin and insulin like growth factor1 promotes angiotenSinogen production and growth in vascular smooth muscle cells [J]. J Hypertens, 2000, 18(8):1051-1056.
[17]Faries PL,Rohan DI,Wyers MC, et al .Vascular smooth muscle cells derived from atheroselerotic human arteries exhibit greater adhesion migration and proliferation than venous cells[J] . J Surg Res,2002,104(1):22-28.
[18]Tonolo G, Melis MG, Formato MF, et al. Additive effects of simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetetic patients[J]. Eur J Clin Invest, 2000,30(11):980-987.
[19]汪俊元,王安才. 他汀类药物对血管重构的干预机制[J]. 心脏杂志,2006,18(3):356-358.
[20]Wassmann S, Laufs U, Baumer AT, et al. Inhibition of geranylgeranylation reduces angiotensin Ⅱmediated free radical production in vascular smooth muscle cells: involvement of angiotensin ATI receptor expression and Rac l GTPase[J]. Mol Pharmacol, 2001,59(3):646-654.
[21]Takemoto M, Node K, Nakagami H, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy[J]. J Clin Invest, 2001,108(10):1429-1437.